Day: April 1, 2023

NIO Inc. Provides March and First Quarter 2023 Delivery Update

NIO Inc. Provides March and First Quarter 2023 Delivery Update

NIO Power Swap station 3.0 NIO Power Swap station 3.0 NIO delivered 10,378 vehicles in March 2023 NIO delivered 31,041 vehicles in the three months ended March 2023, increasing by 20.5% year-over-year Cumulative deliveries of NIO vehicles reached 320,597 as of March 31, 2023 SHANGHAI, China, April 01, 2023 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced its March and first quarter 2023 delivery results. NIO delivered 10,378 vehicles in March 2023. The deliveries consisted of 3,203 premium smart electric SUVs, and 7,175 premium smart electric sedans. NIO delivered 31,041 vehicles in the first quarter of 2023, representing an increase of 20.5% year-over-year. Cumulative deliveries of NIO vehicles...

Continue reading

Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023

Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023

FILSPARI demonstrated a statistically significant, rapid, and sustained decline of proteinuria compared to the active control SAN DIEGO, April 01, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing pivotal, Phase 3 PROTECT Study evaluating FILSPARI™ (sparsentan) in adults with IgA nephropathy (IgAN). The data are simultaneously being presented in a late-breaking trials session at the World Congress of Nephrology 2023, in Bangkok, Thailand. “The data demonstrate the significant and clinically meaningful anti-proteinuric effect of sparsentan compared to irbesartan,” said Brad Rovin, M.D., Medical Director at Ohio State University Center for Clinical Research Management, Director of the Division for...

Continue reading

Long Term Incentive Plans for Executive Management and Other Key Employees in Pandora

Long Term Incentive Plans for Executive Management and Other Key Employees in Pandora

Today, Pandora A/S (“Pandora”) announces the annual grant of performance shares for 2023 under its Long-term incentive plan (“LTIP”), in accordance with its Remuneration Policy. The LTIP provides for a target grant of 28,114 shares (maximum: 56,228 shares) to Pandora’s Executive Management, conditional on performance (i.e., the grant is in the form of Performance shares units (“PSUs”)). In total, considering all participants (Executive Management and key employees) a target grant of 170,000 shares (maximum: 340,000 shares) is provided under the LTIP in 2023. The maximum grant of shares to all participants under the LTIP in 2023 will only be made if the performance conditions set by the Board are achieved at or above stretch targets. Based on the reference share price of DKK 635.80 (the average closing price of Pandora’s shares on Nasdaq...

Continue reading

Prairie Provident Resources Announces Fourth Quarter and Year-End 2022 Financial and Operating Results and Update on Repositioning Plan

Prairie Provident Resources Announces Fourth Quarter and Year-End 2022 Financial and Operating Results and Update on Repositioning Plan

CALGARY, Alberta, April 01, 2023 (GLOBE NEWSWIRE) — Prairie Provident Resources Inc. (“Prairie Provident”, “PPR” or the “Company”) announces our operating and financial results for the fourth quarter and year ended 2022. PPR’s audited annual consolidated financial statements and related Management’s Discussion and Analysis (MD&A) and annual information form dated March 31, 2023 (AIF) are available on our website at www.ppr.ca and filed on SEDAR at www.sedar.com. MESSAGE TO SHAREHOLDERS Although the Company achieved production only slightly (6%) below previously guided volumes, 2022 saw headwinds for Prairie Provident, primarily through $25.5 million of realized hedging losses from mandatory credit facility hedging requirements. When coupled with increasing royalty payments due to higher...

Continue reading

Li Auto Inc. March 2023 Delivery Update

Li Auto Inc. March 2023 Delivery Update

BEIJING, China, April 01, 2023 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that the Company delivered 20,823 vehicles in March 2023, surpassing the 20,000 monthly delivery mark again and representing an increase of 88.7% year over year. This took the Company’s first quarter deliveries to 52,584, up 65.8% year over year. The cumulative deliveries of Li Auto vehicles reached 309,918 as of the end of March. “We have commenced deliveries of Li L7, our five-seat flagship family SUV, and are pleased to hear from its first users that their satisfaction with the vehicle has exceeded their expectation. As of the end of March, we delivered over 300,000 vehicles cumulatively, the fastest among China’s premium NEV manufacturers...

Continue reading

NXT Energy Solutions Announces 2022 Year-End Results

NXT Energy Solutions Announces 2022 Year-End Results

CALGARY, Alberta, March 31, 2023 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX: SFD; OTCQB: NSFDF) today announced the Company’s financial and operating results for the quarter and year ended December 31, 2022 as well as significant subsequent events. All dollar amounts herein are in Canadian Dollars unless otherwise identified. Financial and Operating Highlights Key financial and operational highlights are summarized below: January 25, 2023, the Company closed a Private Placement by issuing 8,510,000 common shares, at $0.195 per common shares, for aggregate gross proceeds of approximately $1,659,450, less issuance costs of $1,170; During December 2022 a rights offering and the first tranche of the private placement contributed $0.43 million of cash; In January, the Board...

Continue reading

Red Pine Announces Upsize of Previously Announced Private Placement to C$6.8 Million

Red Pine Announces Upsize of Previously Announced Private Placement to C$6.8 Million

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO, March 31, 2023 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company“) is pleased to announce that it has entered into an amendment agreement with Haywood Securities Inc. (“Haywood”), as co-lead agent and sole bookrunner, on behalf of 3L Capital Inc. (“3L Capital” and together with Haywood, the “Co-Lead Agents”), as co-lead agent, and a syndicate of agents (together with the Co-Lead Agents, the “Agents”) in connection with a private placement on a “best efforts” agency basis, to increase the size of the previously announced private placement to gross proceeds of up to $6,800,000 (the “Upsized Offering”). The Upsized Offering will consist of any combination...

Continue reading

Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement

Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement

TruGolf, Inc. (“TruGolf”) will become a public company to further advance its software business and increase manufacturing and sales of its golf simulator technology in the United States and internationally. The business combination with Deep Medicine Acquisition Corp. values TruGolf’s at an implied enterprise value of $125 million, including certain payments contingent on future milestones. ● The public listing enables TruGolf to accelerate its software development, golf simulator manufacturing and sales, as well as finalize new-generation hardware and software technology that aim to revolutionize the virtual golf experience.     ● The proceeds from the transaction will enhance TruGolf’s production capacity, new product research and development, working capital and expansion.     ● Mr. Christopher Jones, CEO and Chairman of...

Continue reading

<div>Sabina Gold & Silver Announces Financial Results for the Year Ended December 31, 2022</div>

Sabina Gold & Silver Announces Financial Results for the Year Ended December 31, 2022

VANCOUVER, British Columbia, March 31, 2023 (GLOBE NEWSWIRE) — Sabina Gold & Silver Corp. (“Sabina”) or (the “Company”) (SBB – TSX) reports the financial results for the year ended December 31, 2022. “2022 was a year of continued de-risking at Back River,” said Bruce McLeod, the Company’s President & CEO. “With the completion of our project financing package and related equity financings, we were able to advance the Goose Mine to a formal construction decision. All work since then has been focused on executing and delivering a successful build for first gold in Q1, 2025. Subsequent to the year end, Sabina received a proposal from B2Gold Corp. to purchase all the issued and outstanding shares in the Company in an all-share transaction. After careful consideration, the Board and management of the Company determined that...

Continue reading

AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering

AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering

New York, NY, March 31, 2023 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (the “Company”) (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares (“ADSs”), pre-funded warrants to purchase ADSs and warrants to purchase ADSs in a registered direct offering.  The Company plans to use the net proceeds from the offering for the advancement of our research and development activities, working capital and general corporate purposes. Under the terms of the securities...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.